Archive: 23/02/2017
Study reveals PGK1 enzyme as therapeutic target for deadliest brain cancer
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma, an often fatal form of brain cancer, according to researchers at The University of Texas ...
Feb 23, 2017
Anti-aging gene identified as a promising therapeutic target for older melanoma patients
Scientists at The Wistar Institute have shown that an anti-diabetic drug can inhibit the growth of melanoma in older patients by activating an anti-aging gene that in turn inhibits a protein involved in metastatic progression ...
Feb 23, 2017
Receiving a clot-buster drug before reaching the hospital may reduce stroke disability
Stroke patients receiving clot-busting medications before arriving at the hospital have a lower risk for disability afterward, according to research presented at the American Stroke Association's International Stroke Conference ...
Feb 23, 2017